Transglutaminase is a tumor cell and cancer stem cell survival factor

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|10|947-958

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.10, 2015-10, pp. : 947-958

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase is a tumor cell and cancer stem cell survival factor

By  

Molecular Carcinogenesis, Vol. 899-1987, Iss. 10, 2015-10 ,pp. : 947-958

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphisms at the microRNA binding‐site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer

By  

Molecular Carcinogenesis, Vol. 54, Iss. 6, 2015-06 ,pp. : 449-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Basic fibroblast growth factor shows prognostic impact on survival in operable non‐small cell lung cancer patients

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 450-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

SLC34A2 regulates miR‐25‐Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell‐like cells

By  

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 440-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin polymorphisms associated with overall survival, disease‐free survival, and recurrence in non‐small cell lung cancer patients

By  

Molecular Carcinogenesis, Vol. 54, Iss. S1, 2015-06 ,pp. : E172-E184

John Wiley & Sons Inc

Access to resources Recommend Favorite